2m 2m 2m 2m 2m 2m 2m
PTC Therapeutics (PTCT)
NASDAQ
$66.08+$0.02 (+0.03%)
Price as of Sep 11, 2026 7:47 PM EDT- $5.5BMarket Cap
- 8.14%1-Year Change
- BiotechnologyIndustry
PTC Therapeutics (PTCT)
$66.08+$0.02 (+0.03%)
PTCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $66.06 | ||
Change | -$1.31 (-1.94%) | ||
Open | $67.80 | ||
High | $68.48 | ||
Low | $65.91 | ||
Previous Close | $67.37 | ||
Volume | 792,889 | ||
30-Day Average Volume | 826,566 | ||
1-Week Change | -4.68% | ||
1-Month Change | -10.37% | ||
1-Year Change | 8.14% | ||
3-Year Change | 64.37% | ||
5-Year Change | 58.04% | ||
Fundamentals | |||
Shares Outstanding | 83.5M | ||
Total Assets | $3.3B | ||
Market Cap | $5.5B | ||
Enterprise Value | $5.1B | ||
Period: QTR TTM FY | |||
Revenue | $238.8M | ||
Net Income | $83.5M | ||
Free Cash Flow | $126.9M | ||
EBIT | $146.0M | ||
EBITDA | $161.9M | ||
Net Working Capital | $1.8B | ||
EPS | $0.92 | ||
Enterprise Value/EBITDA | 31 | ||
Enterprise Value/Revenue | 21 | ||
P/B | -33 | ||
P/E | 72 | ||
PEG | 0 | ||
Price/Free Cash Flow | 43 | ||
Price/Operating Cash Flow | 43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue